{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:27:13Z","timestamp":1790015233587,"version":"4.0.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jasc.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:45:17Z","timestamp":1726778717000},"page":"23-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A review of the performance of urinary cytology with a focus on atypia, upper tract and updates on novel ancillary testing"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1968-7280","authenticated-orcid":false,"given":"Olisaemeka","family":"Chukwudebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Vira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-9539","authenticated-orcid":false,"given":"Louis","family":"Vaickus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Shaheen Cocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2024.09.001_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2024.09.001_bib3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1309\/AJCPE1O9YKMRSQKG","article-title":"Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens","volume":"144","author":"McCroskey","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0000000000000118","article-title":"The paris system for reporting urinary cytology: the quest to develop a standardized terminology","volume":"23","author":"Barkan","year":"2016","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib7","series-title":"The Paris System for Reporting Urinary Cytology","author":"Rosenthal","year":"2015"},{"key":"10.1016\/j.jasc.2024.09.001_bib8","series-title":"The Paris System for Reporting Urinary Cytology","author":"Wojcik","year":"2022"},{"key":"10.1016\/j.jasc.2024.09.001_bib9","series-title":"Negative for High-Grade Urothelial Carcinoma (NHGUC)","first-page":"21","author":"VandenBussche","year":"2022"},{"key":"10.1016\/j.jasc.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/jpm12020170","article-title":"The paris system for reporting urinary cytology: a meta-analysis","volume":"12","author":"Nikas","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.jasc.2024.09.001_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jasc.2020.10.002","article-title":"Experience on the use of the paris system for reporting urinary cytopathology: review of the published literature","volume":"10","author":"Pastorello","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cyt.12777","article-title":"The continual impact of the paris system on urine cytology, a 3-year experience","volume":"31","author":"Stanzione","year":"2020","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/cytojournal.cytojournal_30_19","article-title":"Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement","volume":"16","author":"Bakkar","year":"2019","journal-title":"CytoJournal"},{"key":"10.1016\/j.jasc.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cncy.22006","article-title":"A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns","volume":"126","author":"VandenBussche","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jasc.2018.07.006","article-title":"Utility of the paris system for reporting urinary cytology in upper urinary tract specimens","volume":"7","author":"Xing","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jasc.2017.05.005","article-title":"Implementation of the Paris System for Reporting Urinary Cytology results in lower atypical diagnostic rates","volume":"6","author":"Torous","year":"2017","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000452092","article-title":"Applying the Paris System for Reporting Urine Cytology increases the rate of atypical urothelial cells in benign cases: a need for patient management recommendations","volume":"61","author":"Granados","year":"2017","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ajcp\/aqw127","article-title":"Impact of implementing the paris system for reporting urine cytology in the performance of urine cytology: a correlative study of 124 cases","volume":"146","author":"Hassan","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/1055-9965.EPI-12-1386","article-title":"Risk assessment of upper tract urothelial carcinoma related to aristolochic acid","volume":"22","author":"Wu","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jasc.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/dc.23746","article-title":"Upper urinary tract washings outperform voided urine specimens to detect upper tract high-grade urothelial carcinoma","volume":"45","author":"Zhang","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and management of non-metastatic upper tract Urothelial Carcinoma: AUA\/SUO guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00345-023-04446-4","article-title":"Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma","volume":"41","author":"Yonese","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.13935","article-title":"Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis","volume":"120","author":"Marchioni","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bju.14053","article-title":"Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis","volume":"121","author":"Guo","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2016.04.030","article-title":"Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature","volume":"96","author":"Potretzke","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.jasc.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2017.12.009","article-title":"mRNA, microRNA and lncRNA as novel bladder tumor markers","volume":"477","author":"Wieczorek","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jasc.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13148-018-0447-6","article-title":"Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8\/CtIP is almost exclusively methylated in bladder cancer","volume":"10","author":"Mijnes","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13148-018-0496-x","article-title":"Urine cell-based DNA methylation classifier for monitoring bladder cancer","volume":"10","author":"van der Heijden","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2217\/epi-2018-0094","article-title":"A two-gene methylation signature for the diagnosis of bladder cancer in urine","volume":"11","author":"Bosschieter","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.jasc.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1007\/s11033-019-04920-6","article-title":"The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer","volume":"46","author":"Setti","year":"2019","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jasc.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"603.e1","DOI":"10.1016\/j.urolonc.2020.01.007","article-title":"A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade","volume":"38","author":"Hermanns","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/jcm9020605","article-title":"A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions","volume":"9","author":"Monteiro-Reis","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jasc.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1172\/JCI139597","article-title":"Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jasc.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.3390\/ijms21186542","article-title":"The Bladder EpiCheck Test as a non-invasive tool based on the identification of DNA methylation in bladder cancer cells in the Urine: a review of published evidence","volume":"21","author":"Mancini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jasc.2024.09.001_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13148-021-01029-1","article-title":"Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples","volume":"13","author":"Piatti","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.001_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-021-01073-x","article-title":"A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer","volume":"13","author":"Ruan","year":"2021","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.jasc.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/bju.15194","article-title":"Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow-up of non-muscle-invasive bladder cancer: a blinded prospective multicentric study","volume":"127","author":"Gontero","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.urolonc.2020.11.014","article-title":"Novel urinary biomarkers ADXBLADDER and bladder EpiCheck for diagnostics of bladder cancer: A review","volume":"39","author":"Wolfs","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/bco2.338","article-title":"Acu-URO17 is a highly sensitive and specific bladder cancer biomarker","volume":"5","author":"Guo","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.jasc.2024.09.001_bib41","doi-asserted-by":"crossref","first-page":"176.e21","DOI":"10.1016\/j.urolonc.2024.02.012","article-title":"Evaluation of URO17\u00ae to improve non-invasive detection of bladder cancer","volume":"42","author":"Porten","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib42","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3390\/cancers15204987","article-title":"Upper Tract Urothelial Carcinoma (UTUC) diagnosis and risk stratification: a comprehensive review","volume":"15","author":"Bitaraf","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jasc.2024.09.001_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrurol.2015.24","article-title":"Risk-adapted strategy for the kidney-sparing management of upper tract tumours","volume":"12","author":"Seisen","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jasc.2020.08.001","article-title":"High-grade urothelial carcinoma in urine cytology: different spaces - different faces, highlighting morphologic variance","volume":"10","author":"McIntire","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib45","first-page":"657","article-title":"Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract","volume":"10","author":"Potts","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/HC0U-8MEL-9GGV-G9EW","article-title":"Transitional cell carcinoma of the renal pelvis the diagnostic role of pelvic washings","volume":"117","author":"Witte","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/dc.24127","article-title":"The utility of upper urinary tract urine cytology before and after application of the Paris system","volume":"47","author":"Simon","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib48","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/dc.24809","article-title":"Nuclear hypochromasia: shedding light on the \"lightness\" of high-grade urothelial carcinoma","volume":"49","author":"Stern","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/apm.12877","article-title":"Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma","volume":"126","author":"Pierconti","year":"2018","journal-title":"APMIS"},{"key":"10.1016\/j.jasc.2024.09.001_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncy.22343","article-title":"A review of upper urinary tract cytology performance before and after the implementation of The Paris System","volume":"129","author":"Zhang","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/cyt.13328","article-title":"Cytologic evaluation of upper urinary tract specimens: an institutional retrospective study using the paris system for reporting urine cytology second edition with histopathologic follow-up","volume":"35","author":"Khajir","year":"2024","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2024.09.001_bib52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cncy.22792","article-title":"Implementation of the Paris system for reporting urine cytology improves diagnostic accuracy of selective upper urinary tract cytology","volume":"132","author":"Miyai","year":"2024","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib53","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s00345-023-04689-1","article-title":"Positioning the role of urine cytology within the diagnostic pathway for UTUC: supportive but inconclusive","volume":"41","author":"Figaroa","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jasc.2023.12.003","article-title":"Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis","volume":"13","author":"Jia","year":"2024","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/cancers16040758","article-title":"Diagnostic value of urine cytology in pharmacologically forced diuresis for upper tract urothelial carcinoma diagnosis and follow-up","volume":"16","author":"Giudici","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jasc.2024.09.001_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jasc.2014.10.004","article-title":"What is atypia? Use, misuse and overuse of the term atypia in diagnostic cytopathology","volume":"4","author":"Pambuccian","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/dc.24852","article-title":"Clinician's commentary: Atypia in urinary tract cytology specimens","volume":"50","author":"Patel","year":"2022","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jasc.2014.08.001","article-title":"What should not be reported as atypia in urine cytology","volume":"4","author":"Wojcik","year":"2015","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib59","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.5858\/2009-0357-OA.1","article-title":"Limiting the use of atypical\/inconclusive as a category in nongynecologic cytology specimens","volume":"134","author":"Koen","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2024.09.001_bib60","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cncy.21585","article-title":"Young investigator challenge: the accuracy of the nuclear-to-cytoplasmic ratio estimation among trained morphologists","volume":"123","author":"Vaickus","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/dc.23639","article-title":"Accuracy and reproducibility of nuclear\/cytoplasmic ratio assessments in urinary cytology specimens","volume":"45","author":"Layfield","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/cancers12020272","article-title":"Diagnostic agreement for high-grade Urothelial cell carcinoma in atypical urine cytology: a nationwide survey reveals a tendency for overestimation in specimens with an N\/C ratio approaching 0.5","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jasc.2024.09.001_bib63","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/cncy.22445","article-title":"Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features","volume":"129","author":"Nichols","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/dc.24331","article-title":"Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma","volume":"48","author":"Straccia","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib65","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jasc.2023.07.045","article-title":"Variants of high-grade urothelial carcinoma: can we catch them in urine cytology using the paris system?","volume":"12","author":"Xing","year":"2023","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bju.14751","article-title":"Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy","volume":"124","author":"Zamboni","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib67","first-page":"51","article-title":"The real-world lifetime economic burden of urothelial carcinoma by stage at diagnosis","volume":"6","author":"Aly","year":"2020","journal-title":"J Clin Pathw"},{"key":"10.1016\/j.jasc.2024.09.001_bib68","series-title":"Atypical urothelial cells (AUC)","first-page":"63","author":"Barkan","year":"2022"},{"key":"10.1016\/j.jasc.2024.09.001_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.25259\/Cytojournal_48_2021","article-title":"Cytospin performance when using Paris system for reporting urinary cytology","volume":"19","author":"Saharti","year":"2022","journal-title":"Cytojournal"},{"key":"10.1016\/j.jasc.2024.09.001_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12894-022-01005-8","article-title":"The Paris system for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma","volume":"22","author":"Yamasaki","year":"2022","journal-title":"BMC Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000521139","article-title":"Application of the Paris reporting system for urine cytology: the three-year experience of a single tertiary care institute in Thailand","volume":"66","author":"Phruttinarakorn","year":"2022","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2024.09.001_bib72","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncy.22539","article-title":"Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer","volume":"130","author":"Hermans","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/dc.24952","article-title":"The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment","volume":"50","author":"Moulavasilis","year":"2022","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib74","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/diagnostics13162625","article-title":"Diagnosis of low-grade urothelial neoplasm in the era of the second edition of the paris system for reporting urinary cytology","volume":"13","author":"Christofidis","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.jasc.2024.09.001_bib75","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cncy.22726","article-title":"Atypical urothelial cells classified according to the Paris System for Reporting Urinary Cytology: A 2-year experience with histological correlation from a Finnish tertiary care center-low rate and high risk of malignancy","volume":"131","author":"P\u00f6yry","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000527980","article-title":"Evaluation of the implementation and diagnostic accuracy of the paris classification for reporting urinary cytology in voided urine specimens: a cyto-histological correlation study in a cancer center","volume":"90","author":"Lobo","year":"2023","journal-title":"Pathobiology"},{"key":"10.1016\/j.jasc.2024.09.001_bib77","doi-asserted-by":"crossref","first-page":"328","DOI":"10.30699\/ijp.2022.548036.2833","article-title":"Accuracy of Paris 2016 system for non-invasive diagnosis bladder malignancy","volume":"17","author":"Rakhshan","year":"2022","journal-title":"Iran J Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib78","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/dc.25215","article-title":"Application of The Paris System in neobladder washing cytology: comparison between the original diagnosis and correlation with histopathology","volume":"51","author":"Kim","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/dc.25269","article-title":"A comparison between conventional and the Paris systems of reporting urinary cytopathology with a literature update","volume":"52","author":"Kannan","year":"2024","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000529484","article-title":"Atypical category of the Johns Hopkins template has higher risk of malignancy than the Paris system but the Paris system is more applicable for suspicious category","volume":"67","author":"Celik","year":"2023","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2024.09.001_bib81","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4103\/ijpm.ijpm_95_22","article-title":"Quest to develop a standard screening method for urothelial carcinoma using liquid-based cytology (The Paris System) and CK20","volume":"66","author":"Jain","year":"2023","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.jasc.2024.09.001_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jasc.2020.04.015","article-title":"The Paris System \"atypical urothelial cells\" category: can the current criteria be improved?","volume":"10","author":"Vosoughi","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jasc.2020.06.008","article-title":"Targeted education as a method for reinforcing Paris System criteria and reducing urine cytology atypia rates","volume":"10","author":"Compton","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib84","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/dc.24387","article-title":"Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma","volume":"48","author":"Anbardar","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/JOC.JOC_67_18","article-title":"A quest for accuracy: evaluation of The Paris System in diagnosis of urothelial carcinomas","volume":"36","author":"Rai","year":"2019","journal-title":"J Cytol"},{"key":"10.1016\/j.jasc.2024.09.001_bib86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18231\/j.achr.2019.037","article-title":"Implementation of the Paris System versus institutional diagnosis in the performance of urinary cytology: a 5 years correlative study of 74 cases","volume":"4","author":"Vallamreddy","year":"2019","journal-title":"IP Arch Cytol Histopathol Res"},{"key":"10.1016\/j.jasc.2024.09.001_bib87","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cncy.21958","article-title":"Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the \u201catypical\u201d category and an increase in its prediction of subsequent high-grade urothelial carcinoma","volume":"126","author":"Wang","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib88","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/cncy.21999","article-title":"One year of experience using the Paris System for Reporting Urinary Cytology","volume":"126","author":"Meilleroux","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.jasc.2024.09.001_bib89","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cyt.12604","article-title":"Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system","volume":"29","author":"Rohilla","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2024.09.001_bib90","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ajcp\/aqy043","article-title":"A single institutional experience with the Paris System for Reporting Urinary Cytology: correlation of cytology and histology in 194 cases","volume":"150","author":"Zare","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib91","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/cyt.12448","article-title":"An institutional experience with The Paris System: a paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology","volume":"28","author":"Roy","year":"2017","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2024.09.001_bib92","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cyt.12450","article-title":"Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features","volume":"28","author":"Suh","year":"2017","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2024.09.001_bib93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5001\/omj.2011.04","article-title":"The consequence of delayed fixation on subsequent preservation of urine cells","volume":"26","author":"Ahmed","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.jasc.2024.09.001_bib94","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cncy.22349","article-title":"Significant reduction of indeterminate (atypical) diagnosis after implementation of TPS, a single-institution study of more than 27,000 cases","volume":"129","author":"Tian","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib95","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/dc.24166","article-title":"Applying the Paris system for reporting urine cytology to challenging cytology cases","volume":"47","author":"Glass","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib96","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00345-023-04350-x","article-title":"Diagnostic value of Xpert\u00ae BC Detection, Bladder Epicheck\u00ae, Urovysion\u00ae FISH and cytology in the detection of upper urinary tract urothelial carcinoma","volume":"41","author":"Pycha","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib97","article-title":"Xpert\u00ae bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results","volume":"14","author":"D'Elia","year":"2022","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib98","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/JU.0000000000003188","article-title":"A Urine-based DNA methylation marker test to detect upper tract urothelial carcinoma: a prospective cohort study","volume":"209","author":"Ghoreifi","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib99","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ajcp\/aqad116","article-title":"Comparison of DNA methylation and cytology tests in urine to detect upper tract urothelial carcinoma: A paired-design diagnostic study","volume":"161","author":"Wei","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12894-022-01122-4","article-title":"Diagnostic performance of an immunoassay based on urine exfoliated cell enrichment nanotechnology for upper tract urothelial carcinoma: a retrospective, monocentric study","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib101","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.3390\/cancers14215423","article-title":"UroVysionTM fluorescence in situ hybridization in urological cancers: a narrative review and future perspectives","volume":"14","author":"Ke","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jasc.2024.09.001_bib102","doi-asserted-by":"crossref","first-page":"163.e1","DOI":"10.1016\/j.urolonc.2021.08.017","article-title":"Xpert bladder cancer monitor in surveillance of bladder cancer: systematic review and meta-analysis","volume":"40","author":"Sharma","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib103","article-title":"Evaluation of the diagnostic efficiency of voided urine fluorescence in situ hybridization for predicting the pathology of preoperative \"low-risk\" upper tract urothelial carcinoma","volume":"13","author":"Xu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib104","doi-asserted-by":"crossref","first-page":"433.e19","DOI":"10.1016\/j.urolonc.2023.07.007","article-title":"Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma","volume":"41","author":"Katims","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.humpath.2024.04.001","article-title":"Enhancing upper tract urothelial carcinoma diagnosis: utility of cytokeratin 17 and CK20\/CD44\/p53 immunohistochemical panel","volume":"146","author":"Irwin","year":"2024","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib106","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41379-018-0177-5","article-title":"Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia","volume":"32","author":"Babu","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib107","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/pin.13362","article-title":"Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology","volume":"73","author":"Kobayashi","year":"2023","journal-title":"Pathol Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib108","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/00005392-199805000-00057","article-title":"Back propagation neural network in the discrimination of benign from malignant lower urinary tract lesions","volume":"159","author":"Pantazopoulos","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib109","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bju.15518","article-title":"Urine cell image recognition using a deep-learning model for an automated slide evaluation system","volume":"130","author":"Kaneko","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.jasc.2024.09.001_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5569458","article-title":"A calibrated multiexit neural network for detecting urothelial cancer cells","volume":"2021","author":"Lilli","year":"2021","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.jasc.2024.09.001_bib111","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00345-023-04519-4","article-title":"Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial","volume":"41","author":"Lebret","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.jasc.2024.09.001_bib112","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/cyto.a.24313","article-title":"Deep learning based digital cell profiles for risk stratification of urine cytology images","volume":"99","author":"Awan","year":"2021","journal-title":"Cytometry"},{"key":"10.1016\/j.jasc.2024.09.001_bib113","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/cncy.22615","article-title":"Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study","volume":"130","author":"Ou","year":"2022","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib114","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cncy.22176","article-title":"Performance of an artificial intelligence algorithm for reporting urine cytopathology","volume":"127","author":"Sanghvi","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cncy.22099","article-title":"Automating the Paris System for urine cytopathology-A hybrid deep-learning and morphometric approach","volume":"127","author":"Vaickus","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib116","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cncy.22633","article-title":"Uncovering additional predictors of urothelial carcinoma from voided urothelial cell clusters through a deep learning-based image preprocessing technique","volume":"131","author":"Levy","year":"2023","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib117","article-title":"A deep learning system to predict the histopathological results from urine cytopathological images","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jasc.2024.09.001_bib118","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/cncy.22443","article-title":"A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens","volume":"129","author":"Nojima","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2024.09.001_bib119","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/cncy.22725","article-title":"Examining longitudinal markers of bladder cancer recurrence through a semiautonomous machine learning system for quantifying specimen atypia from urine cytology","volume":"131","author":"Levy","year":"2023","journal-title":"Cancer Cytopathol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T21:43:39Z","timestamp":1735681419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294524002096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213294524002096"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2024.09.001","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the performance of urinary cytology with a focus on atypia, upper tract and updates on novel ancillary testing","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Cytopathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}